Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Icatibant Acetate Patent Expiration

Icatibant Acetate is Used for treating acute attacks of hereditary angioedema by antagonizing bradykinin receptor. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Firazyr on Aug 25, 2011. 11 different companies have introduced drugs containing Icatibant Acetate.


Icatibant Acetate Patents

Given below is the list of patents protecting Icatibant Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Firazyr US5648333 Peptides having bradykinin antagonist action Jul 15, 2014

(Expired)

 Takeda Pharms Usa



Icatibant Acetate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Icatibant Acetate Generic API Manufacturers

Several generic applications have been filed for Icatibant Acetate. The first generic version for Icatibant Acetate was by Teva Pharmaceuticals Usa Inc and was approved on Jul 15, 2019. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jun 14, 2024.

Given below is the list of companies who have filed for Icatibant Acetate generic, along with the locations of their manufacturing plants worldwide.


1. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Jun 14, 2024


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Vadodara Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd





2. CAPLIN

Caplin Steriles Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Oct 5, 2020


Manufacturing Plant Locations
New

Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.

Country City Firm Name
United States
Creve Coeur Caplin, Dr David
India
Gummidipoondi Caplin Steriles Limited





3. CIPLA

Cipla Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Jul 13, 2020


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Mumbai Cipla Limited
Vasco Da Gama Cipla Limited
Bangalore Cipla Ltd.
Pithampur, District Dhar Cipla Limited
Raigad Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Bengaluru Cipla Limited





4. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Aug 14, 2023


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





5. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Jun 18, 2020


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Wilson Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)





6. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A May 21, 2021





7. JIANGSU HANSOH PHARM

Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Mar 9, 2020


Manufacturing Plant Locations
New

Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.

Country City Firm Name
China
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd.





8. NANG KUANG PHARM CO

Nang Kuang Pharmaceutical Co Ltd has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Nang Kuang Pharm Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Dec 16, 2020





9. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Jul 15, 2019





10. WILSHIRE PHARMS INC

Wilshire Pharmaceuticals Inc has filed for 1 generic for Icatibant Acetate. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Sep 1, 2020